Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis

Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis: Autoimmune pulmonary alveolar proteinosis (aPAP) is a disease characterized by alveolar filling that leads to progressive accumulation of surfactant in alveoli, hypoxemia, and in some patients, the development of serious infections or pulmonary fibrosis. Although PAP can be caused by multiple…